Ryerson (RYZ) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
18 Mar, 2026Executive summary
Annual meeting scheduled for April 30, 2026, to be held virtually for registered shareholders.
Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report, are available online, with paper copies available upon request.
Voting matters and shareholder proposals
Shareholders will vote on the election of three directors: Jacob Kotzubei, Edward J. Lehner, and Philip E. Norment.
Ratification of KPMG LLP as the independent registered public accounting firm for 2026 is on the agenda.
Approval of the Third Amended and Restated 2014 Omnibus Incentive Plan is proposed.
Amendment to the certificate of incorporation to provide for officer exculpation under Delaware Law will be considered.
Advisory vote on executive compensation (say-on-pay) is included.
Board of directors and corporate governance
Board recommends voting FOR all five main proposals on the agenda.
Latest events from Ryerson
- Shareholders will vote on directors, auditor, incentive plan, officer exculpation, and executive pay.RYZ
Proxy Filing18 Mar 2026 - Merger and expanded credit facility set stage for margin recovery and growth in 2026.RYZ
Q4 202520 Feb 2026 - Q2 profit rose on cost cuts, but Q3 faces weaker demand and lower prices.RYZ
Q2 20242 Feb 2026 - Q3 revenue and margins declined, but cash flow and shareholder returns remained strong.RYZ
Q3 202417 Jan 2026 - Q4 2024 saw a net loss but strong cash flow, cost cuts, and a positive Q1 2025 outlook.RYZ
Q4 202423 Dec 2025 - Virtual annual meeting to vote on directors, auditor, and executive pay; strong governance.RYZ
Proxy Filing1 Dec 2025 - Virtual annual meeting to vote on directors, auditor, and executive pay, with board support.RYZ
Proxy Filing1 Dec 2025 - Q1 2025 revenue rose sequentially, but net loss persisted; Q2 outlook sees higher prices, stable volumes.RYZ
Q1 202528 Nov 2025 - Q2 revenue rose 3% sequentially, but leverage stayed high and Q3 outlook is cautious.RYZ
Q2 202516 Nov 2025